secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0001437749-25-021361
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva prices $10M public offering of 20M shares and warrants at $0.50 per unit
-------------------------------------------------------------------------------

- Offering comprises 20M shares, 20M Series C warrants (5-year, $0.50 exercise), and 20M Series D warrants (12-month, $0.50 exercise).
- Gross proceeds of $10M; net proceeds expected ~$9.0M after fees.
- Net proceeds to fund R&D, working capital, and general corporate purposes.
- Closing expected June 27, 2025; 60-day lock-up on share issuance and one-year variable rate transaction restriction.
- A.G.P./Alliance Global Partners serving as sole placement agent with 7.0% cash fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774925021361/0001437749-25-021361-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774925021361/rvph20250626_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-021361

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer